Abstract
AbstractDurable mechanical circulatory support in the form of left ventricular (LV) assist device (LVAD) therapy is increasingly considered in the context of the recovery of native cardiac function. Progressive improvement in LV function may facilitate LVAD explantation and a resultant reduction in device-related risk. However, ascertaining LV recovery remains a challenge. In this study, we investigated the use of trans-aortic valvular flow rate and trans-LVAD flow rate to assess native LV systolic function using a well-established lumped parameter model of the mechanically assisted LV with pre-existing systolic dysfunction. Trans Aortic Valvular Ejection Fraction (TAVEF) was specifically found to characterize the preload-independent contractility of the LV. It demonstrated excellent sensitivity to simulated pharmacodynamic stress tests and volume infusion tests. TAVEF may prove to be useful in the ascertainment of LV recovery in LVAD-supported LVs with pre-existing LV systolic dysfunction.
Publisher
Cold Spring Harbor Laboratory
Reference26 articles.
1. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events;J Hear Lung Transplant,2017
2. The Society of Thoracic Surgeons Intermacs 2019 Annual Report: The Changing Landscape of Devices and Indications;Ann Thorac Surg,2020
3. Kanwar MK , Selzman CH , Ton V-K , et al.: Clinical myocardial recovery in advanced heart failure with long term left ventricular assist device support J Hear Lung Transplant, 2022
4. Torpoco Rivera DM , Schneider J , Lawrence D , Dentel J , Sehgal S : Successful Explantation of Berlin Heart Excor in Two Young Children ASAIO J, 9900
5. Cardiac Recovery During Long-Term Left Ventricular Assist Device Support